WordNet

any solution that is injected (as into the skin) (同)injectant
the act of putting a liquid into the body by means of a syringe; "the nurse gave him a flu shot" (同)shot
the forceful insertion of a substance under pressure
a projection at the end of a piece of wood that is shaped to fit into a mortise and form a mortise joint

PrepTutorEJDIC

〈U〉〈C〉注射,注入 / 〈C〉注射液
=submarine / (おもにスポーツで)=substitute / =subordinate / 《英》=sublieutenant / =subeditor / 《英》給料の前払い分 / (…の)代役を勤める,代りとなる《+for+名》 / 《英》給料を前借り(前貸し)する / 〈給料〉‘を'前借り(前貸し)する
(木工で)ほぞ

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ブドウ膜炎：治療 uveitis treatment
2. イールズ病 eales disease

English Journal

Cystoid Macular Edema from Cancer-Associated Retinopathy.

Moyer K, Dewilde A, Law C.Author information *OD, FAAO †OD, MS, FAAO Optometry Clinic, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri.AbstractPURPOSE: This article reviews the diagnosis and management of a patient with cancer-associated retinopathy (CAR) secondary to small cell lung cancer who developed a rare presentation of CAR, cystoid macular edema (CME). CAR is a rare cause of unexplained, often rapid, visual acuity and visual field loss.
Optometry and vision science : official publication of the American Academy of Optometry.Optom Vis Sci.2014 Feb 13. [Epub ahead of print]
PURPOSE: This article reviews the diagnosis and management of a patient with cancer-associated retinopathy (CAR) secondary to small cell lung cancer who developed a rare presentation of CAR, cystoid macular edema (CME). CAR is a rare cause of unexplained, often rapid, visual acuity and visual field
PMID 24531653

Treatment of myopic choroidal neovascularization with posterior sub-Tenon's bevacizumab injection (Avastin®).

Liang IC, Chang YY, Lee TS, Lin YR, Liu KR.Author information Cathay General Hospital, Taipei City, Taiwan, ROC.AbstractThe aim of this study was to report the successful treatment of choroidal neovascularization (CNV) in pathologic myopia (PM) with a posterior sub-Tenon bevacizumab (PSTB; Avastin®) injection. The study was a prospective case series including nine eyes of eight patients with PM and CNV. All nine eyes were injected with PSTB (12.5 mg/0.5 ml). Treatment effectiveness was evaluated with optical coherence tomography (OCT). If intraretinal edema or subretinal fluid were detected, injections were repeated after 2 weeks. The main outcome measures were logMAR best-corrected visual acuity (BCVA) and central foveal thickness. The mean follow-up time was 77.56 weeks. BCVA improved by a mean of -0.38 logMAR (>3 lines). The average reduction in absolute central foveal thickness was 25.67 μm. OCT revealed marked CNV volume reduction and fluid-free status in seven eyes. The fluid-free status remained for ≥1 year in these eyes. Fluorescein angiography revealed CNV resolution in three eyes. Corneal stromal penetration of subconjunctival bevacizumab has been demonstrated in animal studies. PSTB may be an equally effective, yet less invasive alternative for the treatment of myopic CNV.
International ophthalmology.Int Ophthalmol.2014 Feb 2. [Epub ahead of print]
The aim of this study was to report the successful treatment of choroidal neovascularization (CNV) in pathologic myopia (PM) with a posterior sub-Tenon bevacizumab (PSTB; Avastin®) injection. The study was a prospective case series including nine eyes of eight patients with PM and CNV. All nine eye
PMID 24488041

Bilateral panuveitis in a patient on vemurafenib BRAF inhibitor therapy for stage IV melanoma.

Agemy SA, Mehta AN, Pachydaki SI, Tewari A.Author information Department of Ophthalmology, Kresge Eye Institute/Wayne State University School of Medicine, Detroit, Michigan - USA.Abstract<bold>Purpose:</bold> To describe a case of recurrent, bilateral panuveitis caused by the BRAF proto-oncogene inhibitor vemurafenib.<bold>Methods:</bold> Case report.<bold>Results:</bold> A 25-year-old woman developed bilateral panuveitis and macular edema after initiating treatment with the BRAF enzyme inhibitor vemurafenib for stage IV cutaneous melanoma. The patient was successfully treated with sub-Tenon triamcinolone injections along with cessation of the medication.<bold>Conclusions:</bold> Panuveitis is a potential adverse effect of vemurafenib. Good communication with oncology is necessary, in case the medication needs to be discontinued.
European journal of ophthalmology.Eur J Ophthalmol.2014 Jan 22:0. doi: 10.5301/ejo.5000423. [Epub ahead of print]
<bold>Purpose:</bold> To describe a case of recurrent, bilateral panuveitis caused by the BRAF proto-oncogene inhibitor vemurafenib.<bold>Methods:</bold> Case report.<bold>Results:</bold> A 25-year-old woman developed
PMID 24474376

Japanese Journal

臨床報告ステロイドテノン囊下注射後に視機能が著明に改善した急性帯状潜在性網膜外層症の1例

眼科 57(5), 787-791, 2015-04
NAID 40020461115

トリアムシノロンアセトニドTenon嚢下注射が有効であった乳頭血管炎の1例

あたらしい眼科 32(1), 149-153, 2015-01
NAID 40020345606

糖尿病黄斑浮腫に対する術前治療の有無による硝子体手術成績の比較

日本眼科學会雜誌 117(10), 785-792, 2013-10-10
NAID 10031201487

Related Pictures

Staggered Sub-Tenon’s Blocks: A Novel Anesthetic Approach for Bilateral Strabismus Sub-Tenon's Steroid Injection | Scott E. Pautler, M.D. Tampa A new technique for delivering sub-Tenon's anaesthesia in ophthalmic surgery -- Amin Sub-Tenon’s injection - American Academy of Ophthalmology Sub-Tenon’s injections - American Academy of Ophthalmology Novel Retrobulbar Anesthesia Technique Through the Sub-Tenon’s Space Using a Sharp clinical case presentation on anterior uveitis